Noah Kornblum

1.6k total citations
52 papers, 384 citations indexed

About

Noah Kornblum is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Noah Kornblum has authored 52 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Noah Kornblum's work include Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (8 papers) and T-cell and Retrovirus Studies (7 papers). Noah Kornblum is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (8 papers) and T-cell and Retrovirus Studies (7 papers). Noah Kornblum collaborates with scholars based in United States, India and Spain. Noah Kornblum's co-authors include Ira Braunschweig, Amit Verma, Olga Derman, Ioannis Mantzaris, Murali Janakiram, Luba Benimetskaya, C.A. Stein, Kanyalakshmi Ayyanar, Bhuvaneswari Ramaswamy and Antonio C. Wolff and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Noah Kornblum

35 papers receiving 378 citations

Peers

Countries citing papers authored by Noah Kornblum

Since Specialization

Citations

This map shows the geographic impact of Noah Kornblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah Kornblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah Kornblum more than expected).

Fields of papers citing papers by Noah Kornblum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noah Kornblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah Kornblum. The network helps show where Noah Kornblum may publish in the future.

Co-authorship network of co-authors of Noah Kornblum

This figure shows the co-authorship network connecting the top 25 collaborators of Noah Kornblum. A scholar is included among the top collaborators of Noah Kornblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noah Kornblum. Noah Kornblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort 2024 ·Transplantation and Cellular Therapy ·M Bakri Hammami, (unknown), Mendel Goldfinger, Nishi Shah, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Marina Konopleva, Aditi Shastri, Lauren Shapiro, Eric J. Feldman, Kira Gritsman, Amit Verma, Dennis Cooper	3
2	Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database 2024 ·Annals of Hematology ·John Yan, M Bakri Hammami, (unknown), Nishi Shah, Mendel Goldfinger, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Alejandro Sica, Dennis Cooper, Eric J. Feldman, Marina Konopleva, Kith Pradhan, (unknown), Charan Thej Reddy Vegivinti, (unknown), (unknown), Swati Goel	0
3	Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia 2024 ·Blood ·(unknown), Ioannis Mantzaris, Aditi Shastri, Kira Gritsman, R. Alejandro Sica, Noah Kornblum, Nishi Shah, David Levitz, Lauren M. Shapiro, Ridhi Gupta, (unknown), (unknown), Karen Fehn, (unknown), (unknown), Dennis Cooper, Marina Konopleva, E. Feldman, Amit Verma, Mendel Goldfinger	0
4	A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML 2023 ·Clinical Cancer Research ·David Levitz, Yogen Saunthararajah, (unknown), Lauren Shapiro, Ioannis Mantzaris, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Nishi Shah, Marina Konopleva, Kira Gritsman, Ira Braunschweig, Dennis Cooper, Kith Pradhan, Amit Verma, Eric J. Feldman, Mendel Goldfinger	10
5	Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population 2023 ·Blood ·(unknown), (unknown), Alex Sisto, (unknown), (unknown), David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis Cooper, Marina Konopleva, Bruce D. Rapkin, Amit Verma, Aditi Shastri, Nishi Shah	1
6	High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events 2023 ·PubMed ·Timothy M. E. Davis, (unknown), (unknown), Lauren Shapiro, Aditi Shastri, Kira Gritsman, Nishi Shah, R. Alejandro Sica, Marina Konopleva, Eric J. Feldman, Ioannis Mantzaris, Ira Braunschweig, Amit Verma, Dennis Cooper, Noah Kornblum, Mendel Goldfinger	0
7	A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx 2023 ·Blood ·(unknown), Alex Sisto, (unknown), (unknown), (unknown), David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis Cooper, (unknown), Bruce D. Rapkin, Amit Verma, Aditi Shastri, Nishi Shah	0
8	AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Lauren M. Shapiro, Ioannis Mantzaris, Aditi Shastri, Alejandro Sica, Nishi Shah, Noah Kornblum, Kira Gritsman, Eric J. Feldman, Amit Verma, Ira Braunschweig, Yogen Saunthararajah, Mendel Goldfinger	0
9	Low-dose weekly decitabine and venetoclax in TP53-mutated myeloid malignancies. 2022 ·Journal of Clinical Oncology ·Lauren Shapiro, Ioannis Mantzaris, Aditi Shastri, Alejandro Sica, Lizamarie Bachier‐Rodriguez, Noah Kornblum, Kira Gritsman, Eric J. Feldman, Amit Verma, Ira Braunschweig, Yogen Saunthararajah, Mendel Goldfinger	1
10	Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML 2021 ·Experimental Hematology and Oncology ·(unknown), (unknown), Nishi Shah, Jiahao Chen, Karen Fehn, Yanhua Wang, Ioannis Mantzaris, Noah Kornblum, Alejandro Sica, (unknown), Mendel Goldfinger, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Aditi Shastri, Amit Verma	9
11	Cardiovascular Side Effects of Chimeric Antigen Receptor (CAR) T-Cell Products: A Single Center Experience in a Minority Rich, Ethnically Diverse Real-World Cohort 2021 ·Blood ·(unknown), Astha Thakkar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kira Gritsman, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, (unknown), Lili Zhang, Amit Verma, Ira Braunschweig, R. Alejandro Sica	0
12	Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center 2019 ·Biology of Blood and Marrow Transplantation ·Diego Adrianzen Herrera, Noah Kornblum, Ana Acuña-Villaorduña, R. Alejandro Sica, Urvi A. Shah, (unknown), (unknown), Nishi Shah, Lizamarie Bachier‐Rodriguez, Olga Derman, Aditi Shastri, Ioannis Mantzaris, Amit Verma, Ira Braunschweig, Murali Janakiram	6
13	Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non–High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Diego Adrianzen Herrera, Noah Kornblum, Olga Derman, Lizamarie Bachier‐Rodriguez, R. Alejandro Sica, Aditi Shastri, Murali Janakiram, Amit Verma, Ira Braunschweig, Ioannis Mantzaris	0
14	Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 2018 ·Journal of Clinical Oncology ·Noah Kornblum, Fengmin Zhao, Judith Manola, Paula Klein, Bhuvaneswari Ramaswamy, Adam Brufsky, Phillip J. Stella, Brian L. Burnette, Melinda L. Telli, Della Makower, P. Cheema, Cristina I. Truica, Antonio C. Wolff, Gamini S. Soori, Barbara Haley, Timothy R. Wassenaar, Lori J. Goldstein, Kathy D. Miller, Joseph A. Sparano	141
15	Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer 2018 ·Targeted Oncology ·Sarah Sammons, Noah Kornblum, Kimberly Blackwell	14
16	Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure 2018 ·Case Reports in Oncological Medicine ·Urvi A. Shah, (unknown), Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit Verma, Yang Shi, John F. Reinus, Olga Derman	0
17	Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Stefan K. Barta, Rishi Jain, (unknown), Jason Carter, (unknown), Roy Browne, (unknown), (unknown), David Kaminetzky, Ramakrishna Battini, Olga Derman, Noah Kornblum, Amit Verma, Ira Braunschweig	5
18	JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association? 2016 ·Biomarker Research ·(unknown), Amit Verma, Olga Derman, Noah Kornblum, Murali Janakiram, Ira Braunschweig, Ramakrishna Battini	2
19	Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck 2011 ·Recent Patents on Anti-Cancer Drug Discovery ·Shahzad Raza, Noah Kornblum, (unknown), Mahadi Baig, (unknown), (unknown)	6
20	Defibrotide, a Polydisperse Mixture of Single-stranded Phosphodiester Oligonucleotides with Lifesaving Activity in Severe Hepatic Veno-occlusive Disease: Clinical Outcomes and Potential Mechanisms of Action 2006 ·Oligonucleotides ·Noah Kornblum, Kanyalakshmi Ayyanar, Luba Benimetskaya, Paul G. Richardson, Massimo Iacobelli, C.A. Stein	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact